CHC-WEST 2016: News in Hematology - Multiple Myeloma Dr. Nizar Bahlis - University of Calgary The…
jwood@krftwrk.caNovember 1, 2016
Management in Relapsed/Refractory Follicular Lymphoma – Dr. Stefano Luminari Unmet needs exist in the R/R…
jwood@krftwrk.caOctober 3, 2016
Staging and Response Assessment in Lymphoma: Dr. Richard Tsang FDG-PET is widely available and funded…
jwood@krftwrk.caSeptember 30, 2016
Plasmacytoma – Dr. Darrel White Solitary plasmacytoma is relatively uncommon, occurring in approximately 5% of…
jwood@krftwrk.caSeptember 30, 2016
A Clinician’s Guide to MPN Diagnosis in 2016 - Dr. Hubert Tsui Revisions to the…
jwood@krftwrk.caSeptember 30, 2016
The MPN World in the JAK2 Inhibitor Era - Dr. Richard Silver Despite the recent advances…
jwood@krftwrk.caSeptember 30, 2016
Management of Ibrutinib Failure – Dr. Matthew Davids The oral BTK inhibitor ibrutinib has revolutionized…
jwood@krftwrk.caSeptember 30, 2016
Non-Hodgkin’s Lymphoma Diffuse large B call lymphoma is the most common subtype of non-Hodgkin lymphoma,…
jwood@krftwrk.caSeptember 28, 2016
Chronic Lymphocytic Leukemia EHA 2016. Abstract LB2070. Whole exome sequencing of 278 chronic lymphocytic leukemia…
jwood@krftwrk.caJuly 13, 2016
